The effect of spirulina on type 2 diabetes: a systematic review and meta-analysis
Tóm tắt
The aim of the present study was to investigate the effect of spirulina on lipid profiles and glycemic related markers in type 2 diabetes patients. PubMed, Scopus, Cochrane Library, ISI Web of Science, and Google Scholar were searched from inception to August 2020. All clinical trials which investigated the effect of spirulina supplementation on glycemic related markers and lipid profile among type 2 diabetes patients were included. Random effects modeling was utilized for pooling analysis to compensate for the between-study heterogeneity. Eight studies (9 arms) were included in the meta-analysis. We found a significant reduction in fasting blood glucose (−17.88 mg/dl; 95% CI: −26.99, −8.78; I2: 25%), triglyceride (−30.99 mg/dl; 95% CI: −45.20, −16.77; I2: 50%), total-cholesterol (−18.47 mg/dl; 95% CI: −33.54, −3.39; I2: 73%), LDL-C (−20.04 mg/dl; 95% CI: −34.06, −6.02; I2: 75%), VLDL (−6.96 mg/dl; 95% CI: −9.71, −4.22; I2: 33%), in addition to a significant increase in HDL-C (−6.96 mg/dl; 95% CI: −9.71, −4.22; I2: 33%), after spirulina administration. No significant effect was observed on HbA1C or post prandial blood sugar following spirulina consumption. The present study suggests that spirulina supplementation can elicit beneficial effects on fasting blood glucose and blood lipid profiles.
Tài liệu tham khảo
Kaiser AB, Zhang N, Van Der Pluijm W. Global prevalence of type 2 diabetes over the next ten years (2018–2028). Am Diabetes Assoc: 2018;67(Supplement 1):202-LB.
Organization WH. WHO global report on trends in prevalence of tobacco smoking 2000–2025. Geneva: World Health Organization; 2018.
Taylor SI. The high cost of diabetes drugs: disparate impact on the Most vulnerable patients. Diabetes Care. 2020;43(10):2330–2.
Wang B, Mu X-L, Zhao J, Jiang H-P, Li S-S, Yan G, et al. Effects of lifestyle interventions on rural patients with type 2 diabetes mellitus. World J Diabetes. 2020a;11(6):261–8.
Hadi A, Pourmasoumi M, Najafgholizadeh A, Kafeshani M, Sahebkar A. Effect of purslane on blood lipids and glucose: a systematic review and meta-analysis of randomized controlled trials. Phytother Res. 2019;33(1):3–12. https://doi.org/10.1002/ptr.6203.
Banerjee M, Khursheed R, Yadav AK, Singh SK, Gulati M, Pandey DK, et al. A systematic review on synthetic drugs and Phytopharmaceuticals used to manage diabetes. Curr Diabetes Rev. 2020;16(4):340–56.
Strain WD, Paldanius P. Diabetes, cardiovascular disease and the microcirculation. Cardiovasc Diabetol. 2018;17(1):57.
Pourmasoumi M, Hadi A, Najafgholizadeh A, Joukar F, Mansour-Ghanaei F. The effects of cranberry on cardiovascular metabolic risk factors: a systematic review and meta-analysis. Clin Nutr. 2019;39(3):774–88.
Hadi A, Pourmasoumi M, Mohammadi H, Symonds M, Miraghajani M. The effects of silymarin supplementation on metabolic status and oxidative stress in patients with type 2 diabetes mellitus: a systematic review and meta-analysis of clinical trials. Complement Ther Med. 2018;41:311–9.
van den Driessche JJ, Plat J, Konings MCJM, Mensink RP. Effects of spirulina and wakame consumption on intestinal cholesterol absorption and serum lipid concentrations in non-hypercholesterolemic adult men and women. Eur J Nutr. 2019;59:2229–36. https://doi.org/10.1007/s00394-019-02073-7.
Ovando CA. Carvalho JCd, Vinícius de Melo Pereira G, Jacques P, Soccol VT, Soccol CR. Functional properties and health benefits of bioactive peptides derived from Spirulina: a review. Food Rev Int. 2018;34(1):34–51.
Wells ML, Potin P, Craigie JS, Raven JA, Merchant SS, Helliwell KE, et al. Algae as nutritional and functional food sources: revisiting our understanding. J Appl Phycol. 2017;29(2):949–82.
Wang Y, Ocampo M, Rodriguez B, Chen J. Resveratrol and Spirulina: Nutraceuticals that potentially improving cardiovascular disease. J Cardiovasc Med Cardiol. 2020b;7:138–45.
Hu S, Fan X, Qi P, Zhang X. Identification of anti-diabetes peptides from Spirulina platensis. J Funct Foods. 2019;56:333–41.
Zhao B, Cui Y, Fan X, Qi P, Liu C, Zhou X, et al. Anti-obesity effects of Spirulina platensis protein hydrolysate by modulating brain-liver axis in high-fat diet fed mice. PLoS One. 2019;14(6):e0218543.
Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med. 2009;151(4):264–9.
Higgins JP, Green S. Cochrane handbook for systematic reviews of interventions. Hoboken: John Wiley & Sons; 2011.
Higgins JPT, Altman DG, Gøtzsche PC, Jüni P, Moher D, Oxman AD, et al. The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. BMJ. 2011;343:d5928. https://doi.org/10.1136/bmj.d5928.
Dersimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177–88. https://doi.org/10.1016/0197-2456(86)90046-2.
Egger M, Smith GD, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. Bmj. 1997;315(7109):629–34.
Sterne J, Bradburn M. Meta-analysis in Stata. In: Egger M, Smith G, Altman D, editors. Systematic Reviews in Health Care 2London. London: BMJ Publishing Group; 2001. p. 347–72.
Alam A, Siddiqui M, Quamri A, Fatima S, Roqaiya M, Ahmad Z. Efficacy of Spirulina (Tahlab) in Patients of Type 2 Diabetes Mellitus (Ziabetus Shakri)-A Randomized Controlled Trial. J Diabetes Metab. 2016;7(10).
Anitha L, Chandralekha K. Effect of supplementation of Spirulina on blood glucose, glycosylated hemoglobin and lipid profile of male non-insulin dependent diabetics. Asian J Exp Biol Sci. 2010;1(1):36–46.
Beihaghi M, Taherzadeh Z. The effects of oral administration of spirulina platensis (cultured Iranian) on blood glucose and glycosylated hemoglobin blood in type ii diabetes mellitus patients. Iran J Diabetes Metab. 2017;16(3):183–90.
Kaur K, Sachdeva R, Grover K. Effect of supplementation of Spirulina on blood glucose and lipid profile of the non-insulin dependent diabetic male subjects. Kidney. 2008;1:5.
Lee EH, Park J-E, Choi Y-J, Huh K-B, Kim W-Y. A randomized study to establish the effects of spirulina in type 2 diabetes mellitus patients. Nutr Res Pract. 2008;2(4):295–300.
Mani U, Desai S, Iyer U. Studies on the long-term effect of spirulina supplementation on serum lipid profile and glycated proteins in NIDDM patients. J Nutraceuticals, Func Med Foods. 2000;2(3):25–32.
Parikh P, Mani U, Iyer U. Role of Spirulina in the control of glycemia and lipidemia in type 2 diabetes mellitus. J Med Food. 2001;4(4):193–9.
Serban M-C, Stoichescu-Hogea G, Gurban C, PETCU F, Jeyakumar D, Andrica F, et al. The role of Spirulina platensis in the control of type 2 diabetes mellitus. BOARD. 1982;96(61.7):27.
Younossi ZM, Golabi P, de Avila L, Paik JM, Srishord M, Fukui N, et al. The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: a systematic review and meta-analysis. J Hepatol. 2019;71(4):793–801.
Paquette M, Bernard S, Ruel I, Blank DW, Genest J, Baass A. Diabetes is associated with an increased risk of cardiovascular disease in patients with familial hypercholesterolemia. J Clin Lipidol. 2019;13(1):123–8.
Ho S-H, Li R, Zhang C, Ge Y, Cao G, Ma M, et al. N-doped graphitic biochars from C-phycocyanin extracted Spirulina residue for catalytic persulfate activation toward nonradical disinfection and organic oxidation. Water Res. 2019;159:77–86.
Memije-Lazaro IN, Blas-Valdivia V, Franco-Colín M, Cano-Europa E. Arthrospira maxima (Spirulina) and C-phycocyanin prevent the progression of chronic kidney disease and its cardiovascular complications. J Funct Foods. 2018;43:37–43.
Shao W, Ebaid R, El-Sheekh M, Abomohra A, Eladel H. Pharmaceutical applications and consequent environmental impacts of Spirulina (Arthrospira): an overview. Grasas Aceites. 2019;70(1):292.
Fan X, Cui Y, Zhang R, Zhang X. Purification and identification of anti-obesity peptides derived from Spirulina platensis. J Funct Foods. 2018;47:350–60.
Karkos P, Leong S, Karkos C, Sivaji N, Assimakopoulos D. Spirulina in clinical practice: evidence-based human applications. Evid Based Complement Alternat Med. 2011;2011:1–4.
Serban M-C, Sahebkar A, Dragan S, Stoichescu-Hogea G, Ursoniu S, Andrica F, et al. A systematic review and meta-analysis of the impact of Spirulina supplementation on plasma lipid concentrations. Clin Nutr. 2016;35(4):842–51.
Hannan J, Ansari P, Azam S, Flatt PR, Wahab YHA. Effects of Spirulina platensis on insulin secretion, DPP-IV activity and both carbohydrate digestion and absorption indicate potential as an adjunctive therapy for diabetes. Br J Nutr. 2020;124(10):1021–34.
Sena CM, Carrilho F, Seiça RM. Endothelial dysfunction in type 2 diabetes: targeting inflammation. Endothelial Dysfunction: Old Concepts and New Challenges. 2018;24:23110.
Oguntibeju OO. Type 2 diabetes mellitus, oxidative stress and inflammation: examining the links. Int J Physio Pathophysiol Pharmacol. 2019;11(3):45.
Oh TJ, Moon JH, Choi SH, Lim S, Park KS, Cho NH, et al. Body-weight fluctuation and incident diabetes mellitus, cardiovascular disease, and mortality: a 16-year prospective cohort study. J Clin Endocrinol Metab. 2019;104(3):639–46.
Barazzoni R, Cappellari GG, Ragni M, Nisoli E. Insulin resistance in obesity: an overview of fundamental alterations. Eat Weight Disord. 2018;23(2):149–57.
Shimobayashi M, Albert V, Woelnerhanssen B, Frei IC, Weissenberger D, Meyer-Gerspach AC, et al. Insulin resistance causes inflammation in adipose tissue. J Clin Invest. 2018;128(4):1538–50.
Gemma C, Mesches MH, Sepesi B, Choo K, Holmes DB, Bickford PC. Diets enriched in foods with high antioxidant activity reverse age-induced decreases in cerebellar β-adrenergic function and increases in proinflammatory cytokines. Journal of Neuroscience. 2002;22(14):6114–20.
de Freitas BA, Silva AS, Ferreira PB, Tavares RL, Neto MM. Spirulina platensis prevents oxidative stress and inflammation promoted by strength training in rats: dose-response relation study. Scientific Reports (Nature Publisher Group). 2020;10(1):6382. https://doi.org/10.1038/s41598-020-63272-5.
Bashir S, Sharif MK, Javed MS, Amjad A, Khan AA, F-u-H S, et al. Safety assessment of Spirulina platensis through Sprague dawley rats modeling. Food Sci Technol. 2020;40(2):376–81.
Marles RJ, Barrett ML, Barnes J, Chavez ML, Gardiner P, Ko R, et al. United States pharmacopeia safety evaluation of Spirulina. Crit Rev Food Sci Nutr. 2011;51(7):593–604.
Hutadilok-Towatana N, Reanmongkol W, Satitit S, Panichayupakaranant P, Ritthisunthorn P. A subchronic toxicity study of Spirulina platensis. Food Sci Technol Res. 2008;14(4):351.
Scaglioni PT, Pagnussatt FA, Lemos AC, Nicolli CP, Del Ponte EM, Badiale-Furlong E. Nannochloropsis sp. and Spirulina sp. as a source of antifungal compounds to mitigate contamination by Fusarium graminearum species complex. Curr Microbiol. 2019;76(8):930–938.